LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 27

Search options

  1. Article ; Online: Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a.

    Caus, Maite / Alonso-Montes, Cristina / Fernandez-Martin, Jose Luis / Marti-Antonio, Manuel / Bozic, Milica / Valdivielso, Jose M

    Arteriosclerosis, thrombosis, and vascular biology

    2023  Volume 43, Issue 8, Page(s) 1533–1548

    Abstract: Background: Vascular calcification (VC) is a highly prevalent complication of chronic kidney disease (CKD) and is associated with the higher morbidity-mortality of patients with CKD. VDR (vitamin D receptor) has been proposed to play a role in the ... ...

    Abstract Background: Vascular calcification (VC) is a highly prevalent complication of chronic kidney disease (CKD) and is associated with the higher morbidity-mortality of patients with CKD. VDR (vitamin D receptor) has been proposed to play a role in the osteoblastic differentiation of vascular smooth muscle cells (VSMCs), but the involvement of vitamin D in VC associated to CKD is controversial. Our aim was to determine the role of local vitamin D signaling in VSMCs during CKD-induced VC.
    Methods: We used epigastric arteries from CKD-affected patients and individuals with normal renal function, alongside an experimental model of CKD-induced VC in mice with conditional deletion of VDR in VSMC. In vitro, experiments in VSMC with or without VDR incubated in calcification media were also used.
    Results: CKD-affected patients and mice with CKD showed an increase in VC, together with increased arterial expression of VDR compared with controls with normal renal function. Conditional gene silencing of VDR in VSMCs led to a significant decrease of VC in the mouse model of CKD, despite similar levels of renal impairment and serum calcium and phosphate levels. This was accompanied by lower arterial expression of OPN (osteopontin) and lamin A and higher expression of SOST (sclerostin). Furthermore, CKD-affected mice showed a reduction of miR-145a expression in calcified arteries, which was significantly recovered in animals with deletion of VDR in VSMC. In vitro, the absence of VDR prevented VC, inhibited the increase of OPN, and reestablished the expression of miR-145a. Forced expression of miR-145a in vitro in VDR
    Conclusions: Our study provides evidence proving that inhibition of local VDR signaling in VSMCs could prevent VC in CKD and indicates a possible role for miR-145a in this process.
    MeSH term(s) Mice ; Animals ; Muscle, Smooth, Vascular/metabolism ; Receptors, Calcitriol/genetics ; Vascular Calcification/genetics ; Vascular Calcification/prevention & control ; Kidney/metabolism ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/genetics ; Renal Insufficiency, Chronic/metabolism ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Vitamin D/metabolism ; Myocytes, Smooth Muscle/metabolism
    Chemical Substances Receptors, Calcitriol ; MicroRNAs ; Vitamin D (1406-16-2)
    Language English
    Publishing date 2023-06-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.122.318834
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical features and disease progression of elderly patients at the ICU setting.

    Rodríguez-García, Raquel / González-Lamuño, Loreto / Santullano, Mario / Martín-Carro, Beatriz / Fernández-Martín, Jose Luis / Cienfuegos Basanta, Maria Del Carmen / Forcelledo, Lorena / Palomo Antequera, Carmen

    Medicina intensiva

    2024  Volume 48, Issue 5, Page(s) 254–262

    Abstract: Objective: To describe and characterize a cohort of octogenarian patients admitted to the ICU of the University Central Hospital of Asturias (HUCA).: Design: Retrospective, observational and descriptive study of 14 months' duration.: Setting: ... ...

    Abstract Objective: To describe and characterize a cohort of octogenarian patients admitted to the ICU of the University Central Hospital of Asturias (HUCA).
    Design: Retrospective, observational and descriptive study of 14 months' duration.
    Setting: Cardiac and Medical intensive care units (ICU) of the HUCA (Oviedo).
    Participants: Patients over 80 years old who were admitted to the ICU for more than 24 h.
    Interventions: None.
    Main variables of interest: Age, sex, comorbidity, functional dependence, treatment, complications, evolution, mortality.
    Results: The most frequent reasons for admission were cardiac surgery and pneumonia. The average admission stay was significantly longer in patients under 85 years of age (p = 0,037). 84,3% of the latter benefited from invasive mechanical ventilation compared to 46,2% of older patients (p = <0,001). Patients over 85 years of age presented greater fragility. Admission for cardiac surgery was associated with a lower risk of mortality (HR = 0,18; 95% CI (0,062-0,527; p = 0,002).
    Conclusions: The results have shown an association between the reason for admission to the ICU and the risk of mortality in octogenarian patients. Cardiac surgery was associated with a better prognosis compared to medical pathology, where pneumonia was associated with a higher risk of mortality. Furthermore, a significant positive association was observed between age and frailty.
    MeSH term(s) Humans ; Aged, 80 and over ; Retrospective Studies ; Male ; Female ; Intensive Care Units/statistics & numerical data ; Disease Progression ; Length of Stay/statistics & numerical data ; Respiration, Artificial/statistics & numerical data ; Cardiac Surgical Procedures ; Hospital Mortality ; Age Factors ; Pneumonia/epidemiology ; Pneumonia/mortality ; Comorbidity ; Spain/epidemiology
    Language English
    Publishing date 2024-03-21
    Publishing country Spain
    Document type Journal Article ; Observational Study
    ISSN 2173-5727
    ISSN (online) 2173-5727
    DOI 10.1016/j.medine.2024.02.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.

    Martín-Vírgala, Julia / Martín-Carro, Beatriz / Fernández-Villabrille, Sara / Ruiz-Torres, María Piedad / Gómez-Alonso, Carlos / Rodríguez-García, Minerva / Fernández-Martín, José Luis / Alonso-Montes, Cristina / Panizo, Sara / Cannata-Andía, Jorge B / Naves-Díaz, Manuel / Carrillo-López, Natalia

    International journal of molecular sciences

    2024  Volume 25, Issue 3

    Abstract: Shortly after the discovery of Klotho, interest grew in its potential role in chronic kidney disease (CKD). There are three isoforms of the Klotho protein: αKlotho, βKlotho and γKlotho. This review will focus on αKlotho due to its relevance as a ... ...

    Abstract Shortly after the discovery of Klotho, interest grew in its potential role in chronic kidney disease (CKD). There are three isoforms of the Klotho protein: αKlotho, βKlotho and γKlotho. This review will focus on αKlotho due to its relevance as a biomarker in CKD. αKlotho is synthesized mainly in the kidneys, but it can be released into the bloodstream and urine as soluble Klotho (sKlotho), which undertakes systemic actions, independently or in combination with FGF23. It is usually accepted that sKlotho levels are reduced early in CKD and that lower levels of sKlotho might be associated with the main chronic kidney disease-mineral bone disorders (CKD-MBDs): cardiovascular and bone disease. However, as results are inconsistent, the applicability of sKlotho as a CKD-MBD biomarker is still a matter of controversy. Much of the inconsistency can be explained due to low sample numbers, the low quality of clinical studies, the lack of standardized assays to assess sKlotho and a lack of consensus on sample processing, especially in urine. In recent decades, because of our longer life expectancies, the prevalence of accelerated-ageing diseases, such as CKD, has increased. Exercise, social interaction and caloric restriction are considered key factors for healthy ageing. While exercise and social interaction seem to be related to higher serum sKlotho levels, it is not clear whether serum sKlotho might be influenced by caloric restriction. This review focuses on the possible role of sKlotho as a biomarker in CKD-MBD, highlighting the difference between solid knowledge and areas requiring further research, including the role of sKlotho in healthy ageing.
    MeSH term(s) Humans ; Biomarkers ; Chronic Kidney Disease-Mineral and Bone Disorder/diagnosis ; Fibroblast Growth Factors ; Glucuronidase ; Healthy Aging/metabolism ; Minerals ; Renal Insufficiency, Chronic/complications ; Klotho Proteins/blood ; Klotho Proteins/metabolism
    Chemical Substances Biomarkers ; Fibroblast Growth Factors (62031-54-3) ; Glucuronidase (EC 3.2.1.31) ; Minerals ; Klotho Proteins (EC 3.2.1.31)
    Language English
    Publishing date 2024-02-03
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms25031843
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Novel Biomarkers of Bone Metabolism.

    Fernández-Villabrille, Sara / Martín-Carro, Beatriz / Martín-Vírgala, Julia / Rodríguez-Santamaria, Mª Del Mar / Baena-Huerta, Francisco / Muñoz-Castañeda, Juan Rafael / Fernández-Martín, José Luis / Alonso-Montes, Cristina / Naves-Díaz, Manuel / Carrillo-López, Natalia / Panizo, Sara

    Nutrients

    2024  Volume 16, Issue 5

    Abstract: Bone represents a metabolically active tissue subject to continuous remodeling orchestrated by the dynamic interplay between osteoblasts and osteoclasts. These cellular processes are modulated by a complex interplay of biochemical and mechanical factors, ...

    Abstract Bone represents a metabolically active tissue subject to continuous remodeling orchestrated by the dynamic interplay between osteoblasts and osteoclasts. These cellular processes are modulated by a complex interplay of biochemical and mechanical factors, which are instrumental in assessing bone remodeling. This comprehensive evaluation aids in detecting disorders arising from imbalances between bone formation and reabsorption. Osteoporosis, characterized by a reduction in bone mass and strength leading to heightened bone fragility and susceptibility to fractures, is one of the more prevalent chronic diseases. Some epidemiological studies, especially in patients with chronic kidney disease (CKD), have identified an association between osteoporosis and vascular calcification. Notably, low bone mineral density has been linked to an increased incidence of aortic calcification, with shared molecules, mechanisms, and pathways between the two processes. Certain molecules emerging from these shared pathways can serve as biomarkers for bone and mineral metabolism. Detecting and evaluating these alterations early is crucial, requiring the identification of biomarkers that are reliable for early intervention. While traditional biomarkers for bone remodeling and vascular calcification exist, they suffer from limitations such as low specificity, low sensitivity, and conflicting results across studies. In response, efforts are underway to explore new, more specific biomarkers that can detect alterations at earlier stages. The aim of this review is to comprehensively examine some of the emerging biomarkers in mineral metabolism and their correlation with bone mineral density, fracture risk, and vascular calcification as well as their potential use in clinical practice.
    MeSH term(s) Humans ; Chronic Kidney Disease-Mineral and Bone Disorder/complications ; Osteoporosis/etiology ; Bone Density/physiology ; Renal Insufficiency, Chronic/complications ; Fractures, Bone/etiology ; Vascular Calcification/complications ; Biomarkers ; Minerals
    Chemical Substances Biomarkers ; Minerals
    Language English
    Publishing date 2024-02-22
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu16050605
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: COSMOS Project: Hemodialysis scenario in Europe.

    Cannata-Andía, Jorge B / Fernández Martín, José Luis

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

    2016  Volume 36, Issue 4, Page(s) 381–388

    Title translation Proyecto COSMOS: escenario de la hemodiálisis en Europa.
    Language Spanish
    Publishing date 2016-07
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 632512-9
    ISSN 1989-2284 ; 0211-6995
    ISSN (online) 1989-2284
    ISSN 0211-6995
    DOI 10.1016/j.nefro.2016.03.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification.

    Fernández-Villabrille, Sara / Martín-Carro, Beatriz / Martín-Vírgala, Julia / Alonso-Montes, Cristina / Palomo-Antequera, Carmen / García-Castro, Raúl / López-Ongil, Susana / Dusso, Adriana S / Fernández-Martín, José Luis / Naves-Díaz, Manuel / Cannata-Andía, Jorge B / Carrillo-López, Natalia / Panizo, Sara

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

    2023  Volume 38, Issue 7, Page(s) 1729–1740

    Abstract: Introduction: MicroRNAs (miRs) regulate vascular calcification (VC), and their quantification may contribute to suspicion of the presence of VC.: Methods: The study was performed in four phases. Phase 1: miRs sequencing of rat calcified and non- ... ...

    Abstract Introduction: MicroRNAs (miRs) regulate vascular calcification (VC), and their quantification may contribute to suspicion of the presence of VC.
    Methods: The study was performed in four phases. Phase 1: miRs sequencing of rat calcified and non-calcified aortas. Phase 2: miRs with the highest rate of change, plus miR-145 [the most abundant miR in vascular smooth muscle cells (VSMCs)], were validated in aortas and serum from rats with and without VC. Phase 3: the selected miRs were analyzed in epigastric arteries from kidney donors and recipients, and serum samples from general population. Phase 4: VSMCs were exposed to different phosphorus concentrations, and miR-145 and miR-486 were overexpressed to investigate their role in VC.
    Results: miR-145, miR-122-5p, miR-486 and miR-598-3p decreased in the rat calcified aortas, but only miR-145 and miR-486 were detected in serum. In human epigastric arteries, miR-145 and miR-486 were lower in kidney transplant recipients compared with donors. Both miRs inversely correlated with arterial calcium content and with VC (Kauppila index). In the general population, the severe VC was associated with the lowest serum levels of both miRs. The receiver operating characteristic curve showed that serum miR-145 was a good biomarker of VC. In VSMCs exposed to high phosphorus, calcium content, osteogenic markers (Runx2 and Osterix) increased, and the contractile marker (α-actin), miR-145 and miR-486 decreased. Overexpression of miR-145, and to a lesser extent miR-486, prevented the increase in calcium content induced by high phosphorus, the osteogenic differentiation and the loss of the contractile phenotype.
    Conclusion: miR-145 and miR-486 regulate the osteogenic differentiation of VSMCs, and their quantification in serum could serve as a marker of VC.
    MeSH term(s) Animals ; Humans ; Rats ; Biomarkers ; Calcium ; MicroRNAs/genetics ; Muscle, Smooth, Vascular ; Myocytes, Smooth Muscle ; Osteogenesis/genetics ; Phosphorus ; Vascular Calcification/genetics
    Chemical Substances Biomarkers ; Calcium (SY7Q814VUP) ; MicroRNAs ; MIRN-598 microRNA, human ; MIRN145 microRNA, human ; MIRN145 microRNA, rat ; MIRN486 microRNA, human ; Phosphorus (27YLU75U4W)
    Language English
    Publishing date 2023-01-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 90594-x
    ISSN 1460-2385 ; 0931-0509
    ISSN (online) 1460-2385
    ISSN 0931-0509
    DOI 10.1093/ndt/gfad027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Redox Metabolism and Vascular Calcification in Chronic Kidney Disease.

    Carrillo-López, Natalia / Panizo, Sara / Martín-Carro, Beatriz / Mayo Barrallo, Juan Carlos / Román-García, Pablo / García-Castro, Raúl / Fernández-Gómez, Jesús María / Hevia-Suárez, Miguel Ángel / Martín-Vírgala, Julia / Fernández-Villabrille, Sara / Martínez-Arias, Laura / Vázquez, Sara Barrio / Calleros Basilio, Laura / Naves-Díaz, Manuel / Cannata-Andía, Jorge Benito / Quirós-González, Isabel / Alonso-Montes, Cristina / Fernández-Martín, José Luis

    Biomolecules

    2023  Volume 13, Issue 9

    Abstract: Vascular calcification (VC) is a common complication in patients with chronic kidney disease which increases their mortality. Although oxidative stress is involved in the onset and progression of this disorder, the specific role of some of the main redox ...

    Abstract Vascular calcification (VC) is a common complication in patients with chronic kidney disease which increases their mortality. Although oxidative stress is involved in the onset and progression of this disorder, the specific role of some of the main redox regulators, such as catalase, the main scavenger of H
    MeSH term(s) Humans ; Animals ; Rats ; Catalase ; Core Binding Factor Alpha 1 Subunit/genetics ; Hydrogen Peroxide ; Oxidation-Reduction ; Vascular Calcification ; Renal Insufficiency, Chronic
    Chemical Substances Catalase (EC 1.11.1.6) ; Core Binding Factor Alpha 1 Subunit ; Hydrogen Peroxide (BBX060AN9V)
    Language English
    Publishing date 2023-09-20
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2701262-1
    ISSN 2218-273X ; 2218-273X
    ISSN (online) 2218-273X
    ISSN 2218-273X
    DOI 10.3390/biom13091419
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients.

    Barrera-Baena, Pedro / Rodríguez-García, Minerva / Rodríguez-Rubio, Enrique / González-Llorente, Lucía / Ortiz, Alberto / Zoccali, Carmine / Locatelli, Francesco / Floege, Jürgen / Cohen-Solal, Martine / Ferreira, Manuel Aníbal / Ketteler, Markus / London, Gerard Michel / Gorriz-Teruel, José Luis / Sánchez-Álvarez, Emilio / Hevia-Suárez, Miguel Ángel / Fernández-Gómez, Jesús María / Martín-Carro, Beatriz / Gómez-Alonso, Carlos / Alonso-Montes, Cristina /
    Cannata-Andia, Jorge Benito / Fernández-Martín, José Luis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

    2023  

    Abstract: Background: Bone fragility fractures are associated with high morbidity and mortality. This study analysed the association between the current biochemical parameters of CKD-MBD and bone fragility fractures in the COSMOS project.: Methods: COSMOS is a ...

    Abstract Background: Bone fragility fractures are associated with high morbidity and mortality. This study analysed the association between the current biochemical parameters of CKD-MBD and bone fragility fractures in the COSMOS project.
    Methods: COSMOS is a 3-year, multicentre, open cohort, prospective, observational study carried out in 6797 hemodialysis patients (227 centres from 20 European countries). The association of bone fragility fractures (outcome) with serum calcium, phosphate and PTH (exposure), was assessed using Standard Cox proportional hazards regression and Cox proportional hazards regression for recurrent events. Additional analyses were performed considering all-cause mortality as a competitive event for bone fragility fracture occurrence. Multivariable models were used in all strategies, with the fully adjusted model including a total of 24 variables.
    Results: During a median follow-up of 24 months 252 (4%) patients experienced at least one bone fragility fracture (incident bone fragility fracture rate 28.5 per 1000 patient-years). In the fractured and non-fractured patients, the percentage of men was 43.7% and 61.4%, mean age 68.1 and 63.8 years and a haemodialysis vintage of 55.9 and 38.3 months respectively. Baseline serum phosphate > 6.1 mg/dL (reference value 4.3-6.1 mg/dL) was significantly associated with a higher bone fragility fracture risk in both regression models (HR: 1.53[95%CI: 1.10-2.13] and HR: 1.44[95%CI: 1.02-2.05]. The significant association persisted after competitive risk analysis (subHR: 1.42[95%CI: 1.02-1.98]) but the finding was not confirmed when serum phosphate was considered as a continuous variable. Baseline serum calcium showed no association with bone fragility fracture risk in any regression model. Baseline serum PTH > 800 pg/mL was significantly associated with a higher bone fragility fracture risk in both regression models, but the association disappeared after a competitive risk analysis.
    Conclusions: Hyperphosphatemia was independently and consistently associated with an increased bone fracture risk, suggesting serum phosphate could be a novel risk factor for bone fractures in hemodialysis patients.
    Language English
    Publishing date 2023-09-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 90594-x
    ISSN 1460-2385 ; 0931-0509
    ISSN (online) 1460-2385
    ISSN 0931-0509
    DOI 10.1093/ndt/gfad190
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Estudios observacionales: el azar y otros dioses.

    Arenas-Fernández, Jorge / Fernández-Martín, José Luis / Cannata-Andía, Jorge B / Martínez-Camblor, Pablo

    Medicina clinica

    2014  Volume 142, Issue 2, Page(s) 80–84

    Title translation Observational studies: the hazard and other gods.
    MeSH term(s) Aged ; Causality ; Chelating Agents/therapeutic use ; Chelation Therapy ; Cohort Studies ; Data Collection ; Female ; Humans ; Hyperparathyroidism, Secondary/blood ; Hyperparathyroidism, Secondary/drug therapy ; Hyperparathyroidism, Secondary/etiology ; Male ; Middle Aged ; Multicenter Studies as Topic/statistics & numerical data ; Observational Studies as Topic/methods ; Observational Studies as Topic/statistics & numerical data ; Phosphorus ; Propensity Score ; Proportional Hazards Models ; Renal Dialysis/adverse effects ; Research Design
    Chemical Substances Chelating Agents ; Phosphorus (27YLU75U4W)
    Language Spanish
    Publishing date 2014-01-21
    Publishing country Spain
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2013.05.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.

    Carrillo-López, Natalia / Martínez-Arias, Laura / Alonso-Montes, Cristina / Martín-Carro, Beatriz / Martín-Vírgala, Julia / Ruiz-Ortega, Marta / Fernández-Martín, José Luis / Dusso, Adriana S / Rodriguez-García, Minerva / Naves-Díaz, Manuel / Cannata-Andía, Jorge B / Panizo, Sara

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

    2020  Volume 36, Issue 4, Page(s) 618–631

    Abstract: Background: In chronic kidney disease, serum phosphorus (P) elevations stimulate parathyroid hormone (PTH) production, causing severe alterations in the bone-vasculature axis. PTH is the main regulator of the receptor activator of nuclear factor κB ( ... ...

    Abstract Background: In chronic kidney disease, serum phosphorus (P) elevations stimulate parathyroid hormone (PTH) production, causing severe alterations in the bone-vasculature axis. PTH is the main regulator of the receptor activator of nuclear factor κB (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system, which is essential for bone maintenance and also plays an important role in vascular smooth muscle cell (VSMC) calcification. The discovery of a new RANKL receptor, leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4), which is important for osteoblast differentiation but with an unknown role in vascular calcification (VC), led us to examine the contribution of LGR4 in high P/high PTH-driven VC.
    Methods: In vivo studies were conducted in subtotally nephrectomized rats fed a normal or high P diet, with and without parathyroidectomy (PTX). PTX rats were supplemented with PTH(1-34) to achieve physiological serum PTH levels. In vitro studies were performed in rat aortic VSMCs cultured in control medium, calcifying medium (CM) or CM plus 10-7 versus 10-9 M PTH.
    Results: Rats fed a high P diet had a significantly increased aortic calcium (Ca) content. Similarly, Ca deposition was higher in VSMCs exposed to CM. Both conditions were associated with increased RANKL and LGR4 and decreased OPG aorta expression and were exacerbated by high PTH. Silencing of LGR4 or parathyroid hormone receptor 1 (PTH1R) attenuated the high PTH-driven increases in Ca deposition. Furthermore, PTH1R silencing and pharmacological inhibition of protein kinase A (PKA), but not protein kinase C, prevented the increases in RANKL and LGR4 and decreased OPG. Treatment with PKA agonist corroborated that LGR4 regulation is a PTH/PKA-driven process.
    Conclusions: High PTH increases LGR4 and RANKL and decreases OPG expression in the aorta, thereby favouring VC. The hormone's direct pro-calcifying actions involve PTH1R binding and PKA activation.
    MeSH term(s) Animals ; Calcium-Regulating Hormones and Agents/pharmacology ; Gene Expression Regulation/drug effects ; Ligands ; Male ; Myocytes, Smooth Muscle/metabolism ; NF-kappa B/metabolism ; Osteoprotegerin/genetics ; Osteoprotegerin/metabolism ; Parathyroid Hormone/pharmacology ; RANK Ligand/genetics ; RANK Ligand/metabolism ; Rats ; Rats, Wistar ; Receptor Activator of Nuclear Factor-kappa B/genetics ; Receptor Activator of Nuclear Factor-kappa B/metabolism ; Receptors, G-Protein-Coupled/genetics ; Receptors, G-Protein-Coupled/metabolism ; Vascular Calcification/metabolism
    Chemical Substances Calcium-Regulating Hormones and Agents ; LGR4 receptor, rat ; Ligands ; NF-kappa B ; Osteoprotegerin ; Parathyroid Hormone ; RANK Ligand ; Receptor Activator of Nuclear Factor-kappa B ; Receptors, G-Protein-Coupled ; Tnfrsf11b protein, rat
    Language English
    Publishing date 2020-12-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 90594-x
    ISSN 1460-2385 ; 0931-0509
    ISSN (online) 1460-2385
    ISSN 0931-0509
    DOI 10.1093/ndt/gfaa290
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top